{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:55:44Z","timestamp":1761929744518},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2875-13-488","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T06:10:13Z","timestamp":1418364613000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea"],"prefix":"10.1186","volume":"13","author":[{"given":"R Joan H","family":"Ingram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelzie","family":"Crenna-Darusallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saraswati","family":"Soebianto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintis","family":"Noviyanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Kevin","family":"Baird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"3666_CR1","doi-asserted-by":"publisher","first-page":"e1814","DOI":"10.1371\/journal.pntd.0001814","volume":"6","author":"PW Gething","year":"2012","unstructured":"Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Mueller I, Baird JK, Hay SI: A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012, 6: e1814-10.1371\/journal.pntd.0001814.","journal-title":"PLoS Negl Trop Dis"},{"key":"3666_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciu245","volume":"1","author":"J Hwang","year":"2014","unstructured":"Hwang J, Cullen KA, Kachur SP, Arguin PM, Baird JK: Severe morbidity and mortality risk from malaria in the United States, 1985\u20132011. Infect Dis. 2014, 1: 1-","journal-title":"Infect Dis"},{"key":"3666_CR3","doi-asserted-by":"publisher","first-page":"a120","DOI":"10.1136\/bmj.a120","volume":"337","author":"AD Smith","year":"2008","unstructured":"Smith AD, Bradely DJ, Smith V, Blaze M, Behrens RH, Chiodini PL, Whitty CJ: Imported malaria and high risk groups: observational study using UK surveillance data. Brit Med J. 2008, 337: a120-10.1136\/bmj.a120.","journal-title":"Brit Med J"},{"key":"3666_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ: Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011, 10: 297-10.1186\/1475-2875-10-297.","journal-title":"Malar J"},{"key":"3666_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-13-144","volume":"13","author":"KE Battle","year":"2014","unstructured":"Battle KE, Karhunen MS, Bhatt S, Gething PW, Howes RE, Golding N, Van Boeckel TP, Messina JP, Shanks GD, Smith DL, Baird JK, Hay SI: Geographical variation in Plasmodium vivax relapse. Malar J. 2014, 13: 144-10.1186\/1475-2875-13-144.","journal-title":"Malar J"},{"key":"3666_CR6","first-page":"23","volume":"7","author":"DE Eyles","year":"1948","unstructured":"Eyles DE, Young MD: Studies on imported malarias. 7. The parasitological pattern of relapsing Plasmodium vivax in military patients. J Nat Malar Soc. 1948, 7: 23-37.","journal-title":"J Nat Malar Soc"},{"key":"3666_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/CMR.00074-12","volume":"26","author":"JK Baird","year":"2013","unstructured":"Baird JK: Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013, 26: 36-57. 10.1128\/CMR.00074-12.","journal-title":"Clin Microbiol Rev"},{"key":"3666_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1.00003-7","volume":"80","author":"NM Anstey","year":"2012","unstructured":"Anstey NM, Douglas NM, Pospoprodjo JR, Price RN: Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2012, 80: 151-201.","journal-title":"Adv Parasitol"},{"key":"3666_CR9","doi-asserted-by":"publisher","first-page":"e29203","DOI":"10.1371\/journal.pone.0029203","volume":"6","author":"L Manning","year":"2011","unstructured":"Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, Warrell J, Rosanas-Urgell A, Lin E, Kiniboro B, Vince J, Hwaiwhanje I, Karunajeewa H, Michon P, Siba P, Mueller I, Davis TM: Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One. 2011, 6: e29203-10.1371\/journal.pone.0029203.","journal-title":"PLoS One"},{"key":"3666_CR10","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1371\/journal.pmed.0050128","volume":"5","author":"E Tjitra","year":"2008","unstructured":"Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN: Multi-drug resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008, 5: e128-10.1371\/journal.pmed.0050128.","journal-title":"PLoS Med"},{"key":"3666_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4269\/ajtmh.12-0610","volume":"91","author":"AM Quispe","year":"2014","unstructured":"Quispe AM, Pozo E, Guerrero E, Durand S, Baldeviano GC, Edgel KA, Graf PC, Lescano AG: Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria?. Am J Trop Med Hyg. 2014, 91: 11-17. 10.4269\/ajtmh.12-0610.","journal-title":"Am J Trop Med Hyg"},{"key":"3666_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/jama.293.2.212","volume":"293","author":"RS Kotwal","year":"2005","unstructured":"Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petrucelli BP: An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA. 2005, 293: 212-216. 10.1001\/jama.293.2.212.","journal-title":"JAMA"},{"key":"3666_CR13","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/424663","volume":"39","author":"JK Baird","year":"2004","unstructured":"Baird JK, Hoffman SL: Primaquine therapy for malaria. Clin Infect Dis. 2004, 39: 1336-1345. 10.1086\/424663.","journal-title":"Clin Infect Dis"},{"key":"3666_CR14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","volume":"75","author":"DR Hill","year":"2006","unstructured":"Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ: Primaquine: a report from the CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg. 2006, 75: 402-415.","journal-title":"Am J Trop Med Hyg"},{"key":"3666_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3329\/jhpn.v27i1.3313","volume":"27","author":"N Khantikul","year":"2009","unstructured":"Khantikul N, Butraporn P, Kim HS, Leemingsawat S, Tempongko MA, Suwonkerd W: Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand. J Health Popul Nutr. 2009, 27: 4-13.","journal-title":"J Health Popul Nutr"},{"key":"3666_CR16","first-page":"1049","volume":"42","author":"JK Baird","year":"2012","unstructured":"Baird JK: Reinventing primaquine for endemic malaria. Expert Opin Emerg Dis. 2012, 42: 1049-1054.","journal-title":"Expert Opin Emerg Dis"},{"key":"3666_CR17","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1128\/AAC.01296-10","volume":"55","author":"J Baird","year":"2011","unstructured":"Baird J: Resistance to chloroquine unhinges vivax malaria therapeutics. Antimicrob Agents Chemother. 2011, 55: 1827-1830. 10.1128\/AAC.01296-10.","journal-title":"Antimicrob Agents Chemother"},{"key":"3666_CR18","first-page":"194","volume-title":"Guidelines for the Treatment of Malaria","author":"WHO","year":"2010","unstructured":"WHO: Guidelines for the Treatment of Malaria. 2010, Geneva: World Health Organization, 194-2","edition":"2"},{"key":"3666_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1473-3099(11)70315-2","volume":"12","author":"MJ Rijken","year":"2012","unstructured":"Rijken MJ, McGready R, Boel E, Poespoprodjo R, Singh N, Syafruddin D, Rogerson S, Nosten F: Malaria in pregnancy in the Asia-Pacific region. Lancet Infect Dis. 2012, 12: 75-88. 10.1016\/S1473-3099(11)70315-2.","journal-title":"Lancet Infect Dis"},{"key":"3666_CR20","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1086\/586743","volume":"46","author":"JR Poespoprodjo","year":"2008","unstructured":"Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN: Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis. 2008, 46: 1374-1381. 10.1086\/586743.","journal-title":"Clin Infect Dis"},{"key":"3666_CR21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4269\/ajtmh.1999.60.687","volume":"60","author":"B Singh","year":"1999","unstructured":"Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman HA: A genus and species specific nested polymerase chain reaction malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 1999, 60: 687-692.","journal-title":"Am J Trop Med Hyg"},{"key":"3666_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","volume":"48","author":"SF Zhou","year":"2009","unstructured":"Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance. Part 1. Clin Pharmacokinet. 2009, 48: 689-723. 10.2165\/11318030-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"key":"3666_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/FPC.0b013e32831ebb30","volume":"19","author":"J Sistonen","year":"2009","unstructured":"Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A: Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at gobal and microgeographic scales. Pharmacogen Genom. 2009, 19: 170-179. 10.1097\/FPC.0b013e32831ebb30.","journal-title":"Pharmacogen Genom"},{"key":"3666_CR24","unstructured":"Microsomes containing metabolizer phenotype-specific CYP2D6 isozyme. http:\/\/www.xenotechllc.com\/products\/subcellular-fractions\/human\/liver\/genotyped\/cyp2d6,"},{"key":"3666_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2710.2012.01333.x","volume":"37","author":"J Jurica","year":"2012","unstructured":"Jurica J, Bartecek R, Zourkova A, Pindurova E, Sulcova A, Kasparek T, Zendulka O: Serum dextromethorphan\/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice. J Clin Pharm Ther. 2012, 37: 486-490. 10.1111\/j.1365-2710.2012.01333.x.","journal-title":"J Clin Pharm Ther"},{"key":"3666_CR26","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJMc1301936","volume":"369","author":"JW Bennett","year":"2013","unstructured":"Bennett JW, Pybus BS, Yadava A, Tosh D, Sousa JC, McCarthy WF, Deye G, Melendez V, Ockenhouse CF: Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N Engl J Med. 2013, 369: 1381-1382. 10.1056\/NEJMc1301936.","journal-title":"N Engl J Med"},{"key":"3666_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.101.2624.377","volume":"101","author":"FC Ehrman","year":"1945","unstructured":"Ehrman FC, Ellis JM, Young MD: Plasmodium vivax Chesson strain. Science. 1945, 101: 377-","journal-title":"Science"},{"key":"3666_CR28","first-page":"171","volume":"7","author":"MD Young","year":"1948","unstructured":"Young MD, Eyles DE, Burgess RW: Studies on imported malaria. 10. An evaluation of the foreign malarias introduced in the United States by returning troops. J Nat Malar Soc. 1948, 7: 171-185.","journal-title":"J Nat Malar Soc"},{"key":"3666_CR29","first-page":"285","volume":"9","author":"JH Edgecomb","year":"1950","unstructured":"Edgecomb JH, Arnold J, Yount EH, Alving AS, Eichelberger L: Primaquine, SN 13272: a new curative agent in vivax malaria. A preliminary report. J Nat Malar Soc. 1950, 9: 285-292.","journal-title":"J Nat Malar Soc"},{"key":"3666_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00210-003-0832-2","volume":"369","author":"UM Zanger","year":"2004","unstructured":"Zanger UM, Raimundo S, Echelbaum M: Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol. 2004, 369: 23-37. 10.1007\/s00210-003-0832-2.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3666_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1475-2875-12-212","volume":"12","author":"BS Pybus","year":"2013","unstructured":"Pybus BS, Marcsisin SR, Jin X, Deye G, Sousa JC, Li Q, Caridha D, Zeng Q, Reichard GA, Ockenhouse C, Bennett J, Walker LA, Ohrt C, Melendez V: The metabolism of primaquine to its active metabolite is dependent on CYP2D6. Malar J. 2013, 12: 212-10.1186\/1475-2875-12-212.","journal-title":"Malar J"},{"key":"3666_CR32","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1016\/S0021-9258(19)50504-X","volume":"267","author":"J Vasquez-Vivar","year":"1992","unstructured":"Vasquez-Vivar J, Augusto O: Hydroxylated metabolites of the antimalarial drug primaquine. J Biol Chem. 1992, 267: 6848-6854.","journal-title":"J Biol Chem"},{"key":"3666_CR33","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4269\/ajtmh.1977.26.1116","volume":"26","author":"LH Schmidt","year":"1977","unstructured":"Schmidt LH, Fradkin R, Vaughan D, Rasco J: Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose. Am J Trop Med Hyg. 1977, 26: 1116-1128.","journal-title":"Am J Trop Med Hyg"},{"key":"3666_CR34","first-page":"621","volume":"22","author":"AS Alving","year":"1960","unstructured":"Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE: Mitigation of the hemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Bull World Health Organ. 1960, 22: 621-631.","journal-title":"Bull World Health Organ"},{"key":"3666_CR35","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","volume":"14","author":"RN Price","year":"2014","unstructured":"Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ: Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014, 14: 982-991. 10.1016\/S1473-3099(14)70855-2. in press","journal-title":"Lancet Infect Dis"},{"key":"3666_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1128\/CMR.00008-09","volume":"22","author":"JK Baird","year":"2009","unstructured":"Baird JK: Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev. 2009, 22: 508-534. 10.1128\/CMR.00008-09.","journal-title":"Clin Microbiol Rev"},{"key":"3666_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1475-2875-11-280","volume":"11","author":"GK John","year":"2012","unstructured":"John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, Price RN: Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J. 2012, 11: 280-10.1186\/1475-2875-11-280.","journal-title":"Malar J"},{"key":"3666_CR38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1128\/AAC.01879-12","volume":"57","author":"I Sutanto","year":"2013","unstructured":"Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, Setiabudy R, Nurleila S, Ekawati LL, Elyazar I, Farrar J, Sudoyo H, Baird JK: Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob Agents Chemother. 2013, 57: 1128-1135. 10.1128\/AAC.01879-12.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-13-488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:37:51Z","timestamp":1630568271000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-13-488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3666"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-13-488","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"29 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"488"}}